Painful necrotic nodules in an immunocompromised patient

Archives of Dermatology

Volumn 146, Issue 4, 2010, Pages

  Huang, Wei Wei ^a   Gray, Cheryl ^a   Bowers, Regina ^a   Walk, Nathan ^a   Lind, Anne ^a   Hornstra, Ian ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; FEMALE; FUSARIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NODULE; SKIN ULCER;

EID: 77951052688     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.39-b     Document Type: Article

References (7)

1. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with haematological malignancy: ten years experience at a cancer center and implications for management. Blood. 1997;90(3):999-1008.
2. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10(suppl 1):67-75.
3. Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med. 2004;25(2):159-169. (Pubitemid 38544248)
4. Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98(2):315-319. (Pubitemid 36828456)
5. Herbrecht R, Nivoix Y, Fohrer C, Natarajan-Amé S, Letscher-Bru V. Management of systemic fungal infections: alternatives to itraconazole. J Antimicrob Chemother. 2005;56(suppl 1):i39-i48. (Pubitemid 41236089)
6. Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis. 2005;40(suppl 6):S401-S408. (Pubitemid 40563297)
7. Raad II, Hachem RY, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006;42(10):1398-1403.